0
0
29 July 2025 — In a development that could revolutionize diabetes care worldwide, researchers have identified a previously unknown subtype of diabetes in children and young people across sub-Saharan Africa. This breakthrough, uncovered in the largest study of its kind in the region, dramatically challenges long-standing global assumptions about the disease.
A Different Diagnosis
Traditionally, type 1 diabetes is characterized as an autoimmune disease where the immune system attacks the insulin-producing cells in the pancreas. However, African clinicians had noticed a puzzling trend: many young patients labeled as having type 1 diabetes did not display the expected autoimmune markers and, in some cases, managed to survive lengthy periods without the typical intensive insulin therapy.
The recent multi-country study, published in The Lancet Diabetes & Endocrinology, found that more than 65% of young people diagnosed with type 1 diabetes in the region lacked both the autoimmune markers and the genetic traits usually seen with the disease. Instead, these patients present symptoms that do not fit the profile for type 2 diabetes or malnutrition-related diabetes, indicating a previously hidden non-autoimmune subtype.
Implications for Treatment
This discovery has significant consequences. Many patients in Africa—and even some in the United States, particularly those of sub-Saharan African descent—may have been misdiagnosed, leading to suboptimal treatment plans. Experts warn that continued reliance on current diagnostic criteria risks mistreating millions and highlights the urgent need for updated diagnostic tools and treatment protocols tailored to regional and genetic differences.
A Call for Broader Research
The study’s authors emphasize the importance of extending research beyond Western populations, which have until now dominated diabetes studies. “These findings are a wake-up call,” said Professor Moffat Nyirenda, a lead author on the study. “They challenge our assumptions about type 1 diabetes and show the disease may present differently in African children and adolescents”.
Researchers are now working to determine the causes behind this novel subtype, investigating possibilities from infections and dietary factors to environmental influences. They stress that finding the root cause could pave the way both for prevention and for new, more effective treatments.
Disclaimer
This article is based on current research findings, including data published in The Lancet Diabetes & Endocrinology. The scientific landscape is constantly evolving, and further studies are required to understand the full implications of this discovery. Individuals should not alter or discontinue prescribed medical treatment without consulting qualified healthcare professionals.
